The effect of nobiletin on behavioral function in elevated plus maze and forced swimming tests in intrahippocampal amyloid beta-induced model of Alzheimer's disease in the rat

1. Canet G, Chevallier N, Zussy C, Desrumaux C, Givalois L. Central Role of Glucocorticoid Receptors in Alzheimer's Disease and Depression. Frontiers in Neuroscience 2018;12:739. 2. Paroni G, Panza F, De Cosmo S, Greco A, Seripa D, Mazzoccoli G. Klotho at the Edge of Alzheimer's Disease and Senile Depression. Molecular Neurobiology 2019;56(3):1908-20. 3. Ross JA, Gliebus G, Van Bockstaele EJ. Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2018;85:136-51. 4. Tu CH, MacDonald I, Chen YH. The Effects of Acupuncture on Glutamatergic Neurotransmission in Depression, Anxiety, Schizophrenia, and Alzheimer's Disease: A Review of the Literature. Frontiers in Psychiatry 2019;10:14. 5. Bi C, Bi S, Li B. Processing of Mutant beta-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer's Disease. Aging and Disease 2019;10(2):383-403. 6. Castellani RJ, Plascencia-Villa G, Perry G. The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation. Laboratory Investigation 2019, in press. 7. Tan JZA, Gleeson PA. The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease. Biochimica et Biophysica acta. Biomembranes 2019;1861(4):697-712. 8. Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer's disease: risk factors and potentially protective measures. Journal of Biomedical Science 2019;26(1):33. 9. Tsuda L, Lim YM. Alzheimer's Disease Model System Using Drosophila. Advances in Experimental Medicine and Biology 2018;1076:25-40. 10. Kimura J, Shimizu K, Kajima K, Yokosuka A, Mimaki Y, Oku N, et al. Nobiletin Reduces Intracellular and Extracellular beta-Amyloid in iPS Cell-Derived Alzheimer's Disease Model Neurons. Biological & Pharmaceutical Bulletin 2018;41(4):451-7. 11. Matsuzaki K, Yamakuni T, Hashimoto M, Haque AM, Shido O, Mimaki Y, et al. Nobiletin restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats. Neuroscience Letters 2006;400(3):230-4. 12. Nakajima A, Aoyama Y, Shin EJ, Nam Y, Kim HC, Nagai T, et al. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Abeta levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD). Behavioural Brain Research 2015;289:69-77. 13. Onozuka H, Nakajima A, Matsuzaki K, Shin RW, Ogino K, Saigusa D, et al. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease. The Journal of Pharmacology and Experimental Therapeutics 2008;326(3):739-44. 14. Seki T, Kamiya T, Furukawa K, Azumi M, Ishizuka S, Takayama S, et al. Nobiletin-rich Citrus reticulata peels, a kampo medicine for Alzheimer's disease: a case series. Geriatrics & Gerontology International 2013;13(1):236-8. 15. Chakraborty S, Lennon JC, Malkaram SA, Zeng Y, Fisher DW, Dong H. Serotonergic system, cognition, and BPSD in Alzheimer's disease. Neuroscience Letters 2019;704:36-44. 16. Cummings J, Lai TJ, Hemrungrojn S, Mohandas E, Yun Kim S, Nair G, et al. Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies. CNS Neuroscience & Therapeutics 2016;22(3):159-66. 17. Victoroff J, Lin FV, Coburn KL, Shillcutt SD, Voon V, Ducharme S. Noncognitive Behavioral Changes Associated With Alzheimer's Disease: Implications of Neuroimaging Findings. The Journal of Neuropsychiatry and Clinical Neurosciences 2018;30(1):14-21. 18. Jan AT, Azam M, Rahman S, Almigeiti AMS, Choi DH, Lee EJ, et al. Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update. Frontiers in Aging Neuroscience 2017;9:356. 19. Marszalek M. Alzheimer's disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides - some aspects. Postepy Higieny i Medycyny Doswiadczalnej (Online) 2016;70(0):787-96. 20. Marszalek M. Alzheimer's disease against peptides products of enzymatic cleavage APP protein: Biological, pathobiological and physico-chemical properties of fibrillating peptides. Postepy Higieny i Medycyny Doswiadczalnej (Online) 2017;71(0):398-410. 21. Ewers M, Mattsson N, Minthon L, Molinuevo JL, Antonell A, Popp J, et al. CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study. Alzheimer's & Dementia 2015;11(11):1306-15. 22. Elfakhri KH, Abdallah IM, Brannen AD, Kaddoumi A. Multi-faceted therapeutic strategy for treatment of Alzheimer's disease by concurrent administration of etodolac and alpha-tocopherol. Neurobiology of Disease 2019;125:123-34. 23. Marttinen M, Takalo M, Natunen T, Wittrahm R, Gabbouj S, Kemppainen S, et al. Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer's Disease. Frontiers in Neuroscience 2018;12:963. 24. Zhang X, Lao K, Qiu Z, Rahman MS, Zhang Y, Gou X. Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease. Journal of Alzheimer's Disease 2019;67(4):1109-22. 25. Elsworthy RJ, Aldred S. Depression in Alzheimer's Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors? Journal of Alzheimer's Disease 2019, in press. 26. Braidy N, Behzad S, Habtemariam S, Ahmed T, Daglia M, Nabavi SM, et al. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease. CNS & Neurological Disorders Drug Targets 2017;16(4):387-97. 27. Huang H, Li L, Shi W, Liu H, Yang J, Yuan X, et al. The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro. Evidence-based Complementary and Alternative Medicine 2016;2016:2918796. 28. Nakajima A, Aoyama Y, Nguyen TT, Shin EJ, Kim HC, Yamada S, et al. Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse. Behavioural Brain Research 2013;250:351-60.